Plasma cell leukemia: advantages of treatment with bortezomib

Author: Fraimout N.  

Publisher: Springer Publishing Company

ISSN: 1776-2596

Source: Targeted Oncology, Vol.3, Iss.4, 2008-10, pp. : 265-267

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract